Skip to content

Homoeopathy treatment of conjunctivitis in school children

Role of Homoeopathy in treatment of conjunctivitis in school children during monsoon season–A pilot Comparative Cohort Study - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073005
Enrollment
144
Registered
2024-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

Intervention1: Individualized homoeopathic medicine based on principles of homoeopathy: 4 pills of indicated homoeopathic medicine to be given in centisimal potency three times a day for 2 days Contro

Sponsors

Central Council for Research in Homoeopathy Janak Puri New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 5-18 years Both genders Children presenting with clinical symptoms of conjunctivitis redness, irritation, discharges, excess tears, itching, dryness, burning, swelling in eyelids with or without history of fever Children willing to give written informed consent or assent to participate in the study Informed consent of parents or guardians who are willing to participate their children in the study

Exclusion criteria

Exclusion criteria: Children suffering from any chronic systemic diseases Children who are taking any medication in past 07 days for conjunctivitis Children wearing lenses and carrying cosmetic in eyesvision abnormality (except spectacles) absent light reflex abnormal pupil size /protrusion of orbit Children suffering from chronic recurrent conjunctivitis, keratitis, non-granulomatous anterior uveitis, nasolasolacrimal duct obstruction, trauma to the eye, corneal ulcer,iritis, sarcoidosis, pharyngoconjunctival pyrexia, orbital cellulitis, herpes zoster infection Children suffering from hyperpyrexia more than 104F

Design outcomes

Primary

MeasureTime frame
1.Severe allergic ocular disease score 2.Numerical rating score for painTimepoint: baseline, 3rd day,7th day and 21 days

Secondary

MeasureTime frame
To determine the “Genus epidemicus ? from this study population according to the principles of Organon of medicine Timepoint: after 21 days

Countries

India

Contacts

Public ContactDr Neha kalra

Central Council for Research in homoeopathy

drnehamehta1985@gmail.com9810518111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026